Stockscreener 앱 받기
2.87
0.00%
0.00
Boundless Bio Inc 주식(BOLD)의 최신 뉴스
Boundless (BOLD) Session: Climbs 1.40% to $2.90 in the Current Update; Trading Range: Price Remains Between $2.75 Support and $3.04 Resistance on the DayFactor Timing - vinanet.vn
Boundless (BOLD) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Shares Show Limited Movement under the Current SnapshotFiscal Year Earnings - vinanet.vn
Boundless Bio (BOLD): ADAR1 Capital discloses 8.8% beneficial ownership stake - Stock Titan
Boundless Bio (BOLD): Citadel entities and Ken Griffin report 0.6% ownership - Stock Titan
Boundless Bio (BOLD) Edges Up to $2.79 as Stock Holds Tight Trading RangeTriple Bottom - Vinanet
Boundless Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Boundless Bio Inc (BOLD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Boundless Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Boundless Bio, Inc. 2Q 2026: Net loss $23.7M, EPS $(1.06) — 10-Q Summary - TradingView
Boundless Bio (Nasdaq: BOLD) plans Serapha merger and dividend - Stock Titan
Boundless Bio (BOLD) Advances 3.57% to $2.90 as Support at $2.75 HoldsBPI Bull Correction - vinanet.vn
Boundless Bio, Inc. Revenue Breakdown – NASDAQ:BOLD - TradingView
Boundless Bio Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView
Boundless Bio Inc (BOLD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Boundless Bio Inc (BOLD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BOLD|Boundless Bio Inc|Price:2.485|Chg%:-0.085 - TradingKey
Boundless Bio Inc (BOLD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Boundless Bio Inc (BOLD) Institutional Confidence - TradingKey
Boundless Bio Inc (BOLD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Boundless Bio Inc (BOLD) Balance Sheet - tradingkey.com
BOLD|Boundless Bio Inc|Price:2.580|Chg%:+0.010 - TradingKey
TradingKey - TradingKey
Boundless Bio Inc (BOLD) Income Statement - TradingKey
Boundless Bio Inc (BOLD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Boundless Bio director Kevin Tang buys $11,865 in shares By Investing.com - Investing.com South Africa
Major Investor Quietly Boosts Stake in Emerging Biotech Player - TipRanks
Form 4 Boundless Bio Inc For: 21 July By Investing.com - Investing.com South Africa
Boundless Bio 10% owner Kevin Tang acquires $11,876 in common shares - Bitget
Boundless Bio director Kevin Tang buys $11,865 in shares - Investing.com
Boundless Bio (NASDAQ: BOLD) major Tang Capital holder adds 4,863 shares - Stock Titan
BOLD Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineEarnings Quality Analysis - vinanet.vn
Boundless Bio Inc. (BOLD) Q1 2026 Earnings: EPS Misses Estimates, Shares Dip Amid Clinical-Stage ChallengesReturn On Assets - dars.gov.et
Boundless Bio Inc. (BOLD) Holds Near Support After Modest DeclineBuyback Factor - dars.gov.et
Tang Capital’s Kevin Tang reports $154,586 Boundless Bio common share purchase - Bitget
Boundless Bio: ten percent owner Kevin Tang buys $155,645 By Investing.com - Investing.com South Africa
Boundless Bio: ten percent owner Kevin Tang buys $155,645 - Investing.com
63,969 shares bought by Tang Capital in Boundless Bio, Inc. (BOLD) - Stock Titan
Form 4 Boundless Bio Inc For: 13 July By Investing.com - Investing.com Nigeria
Tang capital management, Kevin Tang buy $222k Boundless Bio stock By Investing.com - Investing.com Nigeria
Tang capital management, Kevin Tang buy $222k Boundless Bio stock - Investing.com
Boundless Bio (BOLD) Gains 2.45% as Shares Approach Key ResistanceRelative Volume - DonanımHaber
Kevin Tang’s Tang Capital buys $141,864 in Boundless Bio (BOLD) By Investing.com - Investing.com Nigeria
Form 4 Boundless Bio Inc For: 8 July By Investing.com - Investing.com Canada
Ten percent owner of Boundless Bio (NASDAQ: BOLD) adds shares - Stock Titan
Kevin Tang’s Tang Capital buys $141,864 in Boundless Bio (BOLD) - Investing.com
Boundless Bio Inc. (BOLD) Holds Steady at $2.50: Navigating Key Support and Resistance LevelsTechnical Analysis - DonanımHaber
Boundless Bio to merge with Serapha Bio in reverse merger; shares surge - MSN
Form 4 Boundless Bio Inc For: 6 July By Investing.com - Investing.com Nigeria
Boundless Bio ten percent owner Kristina Burow sells $39,840 in stock - Investing.com
Arch venture funds sell $39,840 in Boundless Bio stock - Investing.com
Form 4 Boundless Bio Inc For: 6 July - Investing.com India
Arch venture funds sell $39,840 in Boundless Bio stock By Investing.com - Investing.com Canada
ARCH funds, insiders trade 16,000 Boundless Bio (BOLD) shares - Stock Titan
0.86%
0.31%
자본화:
|
볼륨(24시간):